{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "decreases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uniprot:P04275",
      "entity_text" : "VWF",
      "entity_type" : "protein"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "pubchem:460612",
      "entity_text" : "melphalan",
      "entity_type" : "simple_chemical"
    },
    "hypothesis_information" : false
  },
  "verbose_text" : "VWF concentrate dose was progressively reduced until autologous stem cell transplantation conditioning regimen by melphalan 200 mg/m 2 was attained, with temporary increase during aplasia and discontinuation upon achievement of platelet count> 50 g/L.",
  "reading_complete" : "2020-08-03T12:10:16Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-03T12:09:42Z",
  "trigger" : "reduced",
  "evidence" : [ "VWF concentrate dose was progressively reduced until autologous stem cell transplantation conditioning regimen by melphalan" ],
  "pmc_id" : "7250994",
  "score" : 0
}